Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Financing › Details

Qiagen–SEVERAL: credit, 202409–2031 placement of $500m senior unsecured net share settled convertible bonds due 2031

	Period	2024-09-03 � 2031-01-01
	Money taker	Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA)
	Group	Qiagen (Group)
	Money source	SEVERAL
	Product	investment banking
	Product 2	sample preparation (technology)
	Source	Qiagen N.V.. (9/3/24). "Press Release: Qiagen N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds [not for US, CA, AU, JP, ZA, et al.]". Venlo.

Record changed: 2024-09-11

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Qiagen (Group)

[1] Qiagen N.V.. (9/18/24). "Press Release: Qiagen Expands QIAcuity Digital PCR Offering with over New 100 Assays via GeneGlobe Platform". Venlo....
[2] Qiagen N.V.. (9/12/24). "Press Release: Qiagen and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil’s National Screening Programs". Venlo & Rio de Janeiro....
[3] Qiagen N.V.. (9/4/24). "Press Release: Qiagen and Lilly Collaborate to Support Development of a QIAstat-Dx IVD Panel that Identifies Patients at Risk for Developing Alzheimer’s disease". Venlo....
[4] Qiagen N.V.. (9/3/24). "Press Release: Qiagen N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds [not for US, CA, AU, JP, ZA, et al.]". Venlo....
[5] Evotec SE. (6/3/24). "Press Release: Evotec and Qiagen Enter Software Collaboration for Enhanced Multi-omics Data Insights". Hamburg & Venlo....
[6] Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo....
[7] Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo....
[8] Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA....
[9] Qiagen N.V.. (8/8/23). "Press Release: Qiagen Delivers Ahead of Outlook for Q2 2023 with 9% CER Sales Growth in Non-COVID Products and Updates 2023 Full-year Outlook". Venlo....
[10] Qiagen N.V.. (8/7/23). "Press Release: Qiagen Receives FDA Approval for Companion Diagnostic to Blueprint Medicines’ Ayvakit (avapritinib) in Gastrointestinal Stromal Tumors". Venlo & Germantown, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]